Genetec Technology Berhad

KLSE:GENETEC Stock Report

Market Cap: RM 166.2m

Genetec Technology Berhad Balance Sheet Health

Financial Health criteria checks 3/6

Genetec Technology Berhad has a total shareholder equity of MYR321.0M and total debt of MYR98.2M, which brings its debt-to-equity ratio to 30.6%. Its total assets and total liabilities are MYR477.1M and MYR156.2M respectively.

Key information

30.60%

Debt to equity ratio

RM 98.22m

Debt

Interest coverage ration/a
CashRM 56.00m
EquityRM 320.96m
Total liabilitiesRM 156.19m
Total assetsRM 477.15m

Recent financial health updates

Recent updates

Analysis Article Feb 15

Revenues Working Against Genetec Technology Berhad's (KLSE:GENETEC) Share Price Following 27% Dive

To the annoyance of some shareholders, Genetec Technology Berhad ( KLSE:GENETEC ) shares are down a considerable 27% in...
Analysis Article Nov 04

Genetec Technology Berhad (KLSE:GENETEC) Might Not Be As Mispriced As It Looks After Plunging 26%

Unfortunately for some shareholders, the Genetec Technology Berhad ( KLSE:GENETEC ) share price has dived 26% in the...
Analysis Article Oct 15

Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Sep 02

Genetec Technology Berhad (KLSE:GENETEC) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Unfortunately for some shareholders, the Genetec Technology Berhad ( KLSE:GENETEC ) share price has dived 32% in the...
Analysis Article Aug 26

We Like These Underlying Return On Capital Trends At Genetec Technology Berhad (KLSE:GENETEC)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Analysis Article Jul 22

Calculating The Intrinsic Value Of Genetec Technology Berhad (KLSE:GENETEC)

Key Insights The projected fair value for Genetec Technology Berhad is RM0.75 based on 2 Stage Free Cash Flow to Equity...
Analysis Article May 14

Genetec Technology Berhad (KLSE:GENETEC) Shareholders Will Want The ROCE Trajectory To Continue

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Analysis Article Mar 09

It's Down 27% But Genetec Technology Berhad (KLSE:GENETEC) Could Be Riskier Than It Looks

The Genetec Technology Berhad ( KLSE:GENETEC ) share price has softened a substantial 27% over the previous 30 days...
Analysis Article Feb 13

Need To Know: Analysts Are Much More Bullish On Genetec Technology Berhad (KLSE:GENETEC) Revenues

Genetec Technology Berhad ( KLSE:GENETEC ) shareholders will have a reason to smile today, with the analysts making...
Analysis Article Jan 22

Genetec Technology Berhad (KLSE:GENETEC) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Despite an already strong run, Genetec Technology Berhad ( KLSE:GENETEC ) shares have been powering on, with a gain of...
Analysis Article Dec 08

Genetec Technology Berhad (KLSE:GENETEC) Shares Fly 25% But Investors Aren't Buying For Growth

Genetec Technology Berhad ( KLSE:GENETEC ) shareholders have had their patience rewarded with a 25% share price jump in...
Analysis Article Dec 03

Analysts Just Shaved Their Genetec Technology Berhad (KLSE:GENETEC) Forecasts Dramatically

One thing we could say about the analysts on Genetec Technology Berhad ( KLSE:GENETEC ) - they aren't optimistic...
Analysis Article Nov 28

Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Oct 23

Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Unfortunately for some shareholders, the Genetec Technology Berhad ( KLSE:GENETEC ) share price has dived 25% in the...
Analysis Article Sep 22

Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article Aug 27

Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be

The latest analyst coverage could presage a bad day for Genetec Technology Berhad ( KLSE:GENETEC ), with the analysts...
Analysis Article Aug 19

Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%

The Genetec Technology Berhad ( KLSE:GENETEC ) share price has fared very poorly over the last month, falling by a...
Analysis Article Aug 06

Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Feb 26

Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable

With a price-to-earnings (or "P/E") ratio of 28.4x Genetec Technology Berhad ( KLSE:GENETEC ) may be sending very...
Analysis Article Jan 15

Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
Analysis Article Sep 22

Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders

Key Insights Genetec Technology Berhad to hold its Annual General Meeting on 29th of September Salary of RM829.2k is...
Analysis Article Feb 08

Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article Dec 28

Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article Nov 17

Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Aug 16

Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article Jul 21

Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Financial Position Analysis

Short Term Liabilities: GENETEC's short term assets (MYR331.9M) exceed its short term liabilities (MYR155.3M).

Long Term Liabilities: GENETEC's short term assets (MYR331.9M) exceed its long term liabilities (MYR850.0K).


Debt to Equity History and Analysis

Debt Level: GENETEC's net debt to equity ratio (13.2%) is considered satisfactory.

Reducing Debt: GENETEC's debt to equity ratio has increased from 22% to 30.6% over the past 5 years.

Debt Coverage: GENETEC's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if GENETEC's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/07 08:24
End of Day Share Price 2026/05/07 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genetec Technology Berhad is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhen Ye KhooCLSA
null nullMercury Securities Sdn. Bhd